Mesa Laboratories Inc (MLAB) is now in the Overvalued zone, suggesting that its current forward PE ratio of 62.30 is considered Overvalued compared with the five-year average of 31.46. The fair price of Mesa Laboratories Inc (MLAB) is between 31.31 to 70.56 according to relative valuation method. Compared to the current price of 93.24 USD , Mesa Laboratories Inc By Overvalued By 32.14%.

Relative Value

Fair Zone

31.31-70.56

Current Price：93.24

32.14%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Mesa Laboratories Inc (MLAB) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Mesa Laboratories Inc (MLAB) has a current Price-to-Book (P/B) ratio of 2.45. Compared to its 3-year average P/B ratio of 2.88, the current P/B ratio is approximately -14.88% higher. Relative to its 5-year average P/B ratio of 2.99, the current P/B ratio is about -17.93% higher. Mesa Laboratories Inc (MLAB) has a Forward Free Cash Flow (FCF) yield of approximately 8.49%. Compared to its 3-year average FCF yield of 6.52%, the current FCF yield is approximately 30.27% lower. Relative to its 5-year average FCF yield of 4.92%, the current FCF yield is about 72.53% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MLAB competitors is 3.06, providing a benchmark for relative valuation. Mesa Laboratories Inc Corp (MLAB.O) exhibits a P/S ratio of 1.73, which is -43.46% above the industry average. Given its robust revenue growth of 3.64%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MLAB increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MLAB in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MLAB currently overvalued or undervalued?

What is Mesa Laboratories Inc (MLAB) fair value?

MLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Mesa Laboratories Inc (MLAB) is between 31.31 to 70.56 according to relative valuation method.

How does MLAB's valuation metrics compare to the industry average?

The average P/S ratio for MLAB's competitors is 3.06, providing a benchmark for relative valuation. Mesa Laboratories Inc Corp (MLAB) exhibits a P/S ratio of 1.73, which is -43.46% above the industry average. Given its robust revenue growth of 3.64%, this premium appears unsustainable.

What is the current P/B ratio for Mesa Laboratories Inc (MLAB) as of Mar 03 2026?

As of Mar 03 2026, Mesa Laboratories Inc (MLAB) has a P/B ratio of 2.45. This indicates that the market values MLAB at 2.45 times its book value.

What is the current FCF Yield for Mesa Laboratories Inc (MLAB) as of Mar 03 2026?

As of Mar 03 2026, Mesa Laboratories Inc (MLAB) has a FCF Yield of 8.49%. This means that for every dollar of Mesa Laboratories Inc's market capitalization, the company generates 8.49 cents in free cash flow.

What is the current Forward P/E ratio for Mesa Laboratories Inc (MLAB) as of Mar 03 2026?

As of Mar 03 2026, Mesa Laboratories Inc (MLAB) has a Forward P/E ratio of 62.30. This means the market is willing to pay $62.30 for every dollar of Mesa Laboratories Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Mesa Laboratories Inc (MLAB) as of Mar 03 2026?

As of Mar 03 2026, Mesa Laboratories Inc (MLAB) has a Forward P/S ratio of 1.73. This means the market is valuing MLAB at $1.73 for every dollar of expected revenue over the next 12 months.

MLAB Valuation